Patents by Inventor Chengrun TANG

Chengrun TANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11447470
    Abstract: Disclosed is a pyrimidinone-containing compound represented by formula I, a preparation method thereof, a pharmaceutical composition, and an application thereof. The pyrimidinone-containing compound of the present disclosure can be used as HIV-1 inhibitor and can be also used in the treatment of human immunodeficiency virus infection.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: September 20, 2022
    Assignees: Yunnan University, Kunming Institute of Zoology, Chinese Academy of Sciences
    Inventors: Yanping He, Hongbin Zhang, Yongtang Zheng, Yumeng Wu, Chengrun Tang, Ruomei Rui, Liumeng Yang, Jiangyuan Wang
  • Patent number: 11420959
    Abstract: Disclosed is a DACOs-type NNRTIs amino acid ester derivative, a preparation method thereof, a pharmaceutical composition, and an application thereof. The structure of the DACOs-type NNRTIs amino acid ester derivative is represented by formula (I). The DACOs-type NNRTIs amino acid ester derivative represented by formula (I) can be used as HIV-1 inhibitors and for the preparation of a drug for treating and/or preventing immunodeficiency viruses.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: August 23, 2022
    Assignees: Yunnan University, Kunming Institute of Zoology, Chinese Academy of Sciences
    Inventors: Yanping He, Hongbin Zhang, Yongtang Zheng, Yufang Zhang, Chengrun Tang, Wei Ding, Liumeng Yang, Yiming Li
  • Publication number: 20210040069
    Abstract: Disclosed is a DACOs-type NNRTIs amino acid ester derivative, a preparation method thereof, a pharmaceutical composition, and an application thereof. The structure of the DACOs-type NNRTIs amino acid ester derivative is represented by formula (I). The DACOs-type NNRTIs amino acid ester derivative represented by formula (I) can be used as HIV-1 inhibitors and for the preparation of a drug for treating and/or preventing immunodeficiency viruses.
    Type: Application
    Filed: March 4, 2019
    Publication date: February 11, 2021
    Inventors: Yanping HE, Hongbin ZHANG, Yongtang ZHENG, Yufang ZHANG, Chengrun TANG, Wei DING, Liumeng YANG, Yiming LI
  • Publication number: 20200399248
    Abstract: Disclosed is a pyrimidinone-containing compound represented by formula I, a preparation method thereof, a pharmaceutical composition, and an application thereof. The pyrimidinone-containing compound of the present disclosure can be used as HIV-1 inhibitor and can be also used in the treatment of human immunodeficiency virus infection.
    Type: Application
    Filed: March 4, 2019
    Publication date: December 24, 2020
    Inventors: Yanping HE, Hongbin ZHANG, Yongtang ZHENG, Yumeng WU, Chengrun TANG, Ruomei RUI, Liumeng YANG, Jiangyuan WANG